TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage August 7, 1998
TCL Archive ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation January 23, 2009